000			01940 a2200517 4500
005			20250516072750.0
264		0	_c20120816
008			201208s 0 0 eng d
022			_a1573-904X
024	7		_a10.1007/s11095-012-0667-y _2doi
040			_aNLM _beng _cNLM
100	1		_aFu, Ailing
245	0	0	_aTargeted delivery of proteins into the central nervous system mediated by rabies virus glycoprotein-derived peptide. _h[electronic resource]
260			_bPharmaceutical research _cJun 2012
300			_a1562-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aBlood-Brain Barrier _xmetabolism
650	0	4	_aBrain-Derived Neurotrophic Factor _xadministration & dosage
650	0	4	_aCapillary Permeability
650	0	4	_aChemistry, Pharmaceutical
650	0	4	_aDisease Models, Animal
650	0	4	_aDrug Carriers
650	0	4	_aDrug Compounding
650	0	4	_aGlycoproteins _xadministration & dosage
650	0	4	_aHalf-Life
650	0	4	_aHumans
650	0	4	_aInfarction, Middle Cerebral Artery _xdrug therapy
650	0	4	_aInjections, Intravenous
650	0	4	_aLuciferases _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aNeuroprotective Agents _xadministration & dosage
650	0	4	_aPeptide Fragments _xadministration & dosage
650	0	4	_aRabies virus _xmetabolism
650	0	4	_aRecombinant Fusion Proteins _xadministration & dosage
650	0	4	_aTechnology, Pharmaceutical _xmethods
650	0	4	_aTissue Distribution
650	0	4	_aViral Proteins _xadministration & dosage
650	0	4	_abeta-Galactosidase _xadministration & dosage
700	1		_aWang, Yilin
700	1		_aZhan, Liping
700	1		_aZhou, Rumei
773	0		_tPharmaceutical research _gvol. 29 _gno. 6 _gp. 1562-9
856	4	0	_uhttps://doi.org/10.1007/s11095-012-0667-y _zAvailable from publisher's website
999			_c21448801 _d21448801